Basiliximab plus low-dose cyclosporin vs. OKT3 for induction immunosuppression following renal transplantation.
Kode R, Fa K, Chowdhury S, Ranganna K, Fyfe B, Stabler S, Damask A, Laftavi MR, Kumar AM, Pankewycz O. Basiliximab plus low-dose cyclosporin vs. OKT3 for induction immunosuppression following renal transplantation. Clin Transplant. 2003 Aug; 17(4):369-76.